Share-Based Compensation (Stock Appreciation Rights Activity) (Details) - USD ($)	9 Months Ended
	Nov. 02, 2019	Nov. 03, 2018
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at February 3, 2018	1,041,867
Number of Underlying Shares, Granted	0
Number of Underlying Shares, Exercised	(43,463)
Number of Underlying Shares, Forfeited	(201,679)
Number of Underlying Shares, Ending Balance at August 4, 2018	796,725
Number of Underlying shares, Stock appreciation rights exercisable	796,100
Number of Underlying Shares, Stock appreciation rights expected to become exercisable	607
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance at February 3, 2018	$ 37.81
Weighted-Average Exercise Price, Granted	0
Weighted-Average Exercise Price, Exercised	22.41
Weighted-Average Exercise Price, Forfeited or expired	32.27
Weighted-Average Grant Date Fair Value, Ending Balance at August 4, 2018	40.06
Weighted-Average Exercise Price, Stock appreciation rights exercisable	40.08
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable	$ 22.55
Aggregate Intrinsic Value, Outstanding	$ 0
Aggregate Intrinsic Value, Stock appreciation rights exercisable	0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	2 years 7 months 6 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 7 months 6 days
Weighted Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	6 years 2 months 12 days
Stock Appreciation Rights
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 620,000	$ 1,279,000